[go: up one dir, main page]

Gutensohn et al., 2013 - Google Patents

Validation of cord blood split products prepared by an automated method

Gutensohn et al., 2013

Document ID
13000459263769515381
Author
Gutensohn K
Odendahl M
Kersten J
Tonn T
Publication year
Publication venue
Transfusion Medicine

External Links

Snippet

Objectives In this study, we studied whether the contents of the two compartments of automatically processed cord blood (CB) units are comparable with respect to cell counts and viability and therefore suitable for clinical therapy. Background CB‐derived stem cells …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0647Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081Purging biological preparations of unwanted cells
    • C12N5/0087Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Rubinstein Cord blood banking for clinical transplantation
Chen et al. Comparison of the effects of different cryoprotectants on stem cells from umbilical cord blood
Armitage et al. Cord blood banking: volume reduction of cord blood units using a semi-automated closed system
Briard et al. Small-molecule ice recrystallization inhibitors improve the post-thaw function of hematopoietic stem and progenitor cells
Solves et al. Qualitative and quantitative cell recovery in umbilical cord blood processed by two automated devices in routine cord blood banking: a comparative study
Frisch et al. Hematopoietic stem cell cultures and assays
AU2012217778B2 (en) Stem cells packaging and shipping
Meyer et al. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood
Solves et al. Red blood cell depletion with a semiautomated system or hydroxyethyl starch sedimentation for routine cord blood banking: a comparative study
Lanza et al. Manipulation, and cryopreservation of autologous peripheral blood stem cell products in Italy: A survey by GITMO, SIDEM and GIIMA societies
Kao et al. Validation of short‐term handling and storage conditions for marrow and peripheral blood stem cell products
Watt et al. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use
Appleman et al. Cryopreservation of canine platelets
Lawce et al. Peripheral blood cytogenetic methods
Querol et al. Direct immunomagnetic method for CD34+ cell selection from cryopreserved cord blood grafts for ex vivo expansion protocols
Gniadek et al. Optimal storage conditions for apheresis research (OSCAR): a biomedical excellence for safer transfusion (BEST) collaborative study
Jansen et al. Transportation of peripheral blood progenitor cell products: effects of time, temperature and cell concentration
Scott et al. Use of liquid patient ascites fluids as a preclinical model for oncolytic virus activity
Martin‐Henao et al. Cryopreservation of hematopoietic progenitor cells from apheresis at high cell concentrations does not impair the hematopoietic recovery after transplantation
Gutensohn et al. Validation of cord blood split products prepared by an automated method
Eichler et al. Engraftment capacity of umbilical cord blood cells processed by either whole blood preparation or filtration
Heuer et al. Flow cytometric characterization of hematopoietic stem and progenitor cell subpopulations in autologous peripheral blood stem cell preparations after cryopreservation
Frisch Hematopoietic stem cell cultures and assays
Tran et al. Optimized processing of growth factor mobilized peripheral blood CD34+ products by counterflow centrifugal elutriation
Jansen et al. Transportation of peripheral blood progenitor cell products: effect of ambient temperature